Kanamycin

Overview

Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. Kanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate.

Indication

For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.

Associated Conditions

Bacterial Infection caused by Acinetobacter species
Bacterial Infection caused by E. coli
Bacterial Infection caused by Enterobacter aerogenes
Bacterial Infection caused by Klebsiella Pneumoniae
Bacterial Infection caused by Proteus species
Bacterial Infection caused by Serratia marcescens

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis	2015/05/27	NCT02454205	Phase 2	Completed	University of Cape Town
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB	2015/04/06	NCT02409290	Phase 3	Completed	IUATLD, Inc
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis	2009/01/01	NCT00816426	Phase 1	Completed	National Institute of Allergy and Infectious Diseases (NIAID)
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy	2002/08/01	NCT00042289	N/A	Completed	National Institute of Allergy and Infectious Diseases (NIAID)

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
KANAMYCIN MEIJI FOR INJECTION 1 g/vial	Thai Meiji Pharmaceutical Co., Ltd	SIN02356P	INJECTION, POWDER, FOR SOLUTION	1 g/vial	10/21/1988
KANAMYCIN SULFATE INJECTION 1 g/3 ml	THAI MEIJI PHARMACEUTICAL CO LTD	SIN01963P	INJECTION	1 g/3 ml	6/23/1988

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access